共 50 条
A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin
被引:0
|作者:
Howard N. Bockbrader
David Wesche
Raymond Miller
Sunny Chapel
Nancy Janiczek
Paula Burger
机构:
[1] Pfizer Global Research & Development,
[2] Pfizer Global Research & Development,undefined
来源:
关键词:
Neuropathic Pain;
Gabapentin;
Pregabalin;
Postherpetic Neuralgia;
Pain Score Reduction;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Pregabalin and gabapentin share a similar mechanism of action, inhibiting calcium influx and subsequent release of excitatory neurotransmitters; however, the compounds differ in their pharmacokinetic and pharmacodynamic characteristics. Gabapentin is absorbed slowly after oral administration, with maximum plasma concentrations attained within 3–4 hours. Orally administered gabapentin exhibits saturable absorption — a nonlinear (zero-order) process — making its pharmacokinetics less predictable. Plasma concentrations of gabapentin do not increase proportionally with increasing dose. In contrast, orally administered pregabalin is absorbed more rapidly, with maximum plasma concentrations attained within 1 hour. Absorption is linear (first order), with plasma concentrations increasing proportionately with increasing dose. The absolute bioavailability of gabapentin drops from 60% to 33% as the dosage increases from 900 to 3600 mg/day, while the absolute bioavailability of pregabalin remains at <-90% irrespective ofthe dosage. Both drugs can be given without regard to meals. Neither drug binds to plasma proteins. Neither drug is metabolized by nor inhibits hepatic enzymes that are responsible for the metabolism of other drugs. Both drugs are excreted renally, with elimination half-lives of approximately 6 hours.
引用
收藏
页码:661 / 669
页数:8
相关论文